Silence Therapeutics plc (SLN) stock forecast and price target
Price $19.83 · data as of November 13, 2026
12-month price target
Average target$19.75
Upside / downside−0.4%
Analysts4
ConsensusHold
Low $19.00Average $19.75High $20.00
Gold marker: average target · white marker: today’s price ($19.83)
Analyst ratings
Strong buy 0Buy 1Hold 4Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.03 | +44.3% | $314880 |
| Next fiscal year ends December 31, 2027 | $-0.80 | +22.3% | $741880 |
| Next quarter ends December 31, 2026 | $-0.24 | +11.1% | $4500 |
| Quarter after ends March 31, 2027 | $-0.17 | — | $67000 |
Consensus of the analysts covering Silence Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Silence Therapeutics stock price target?
The average 12-month target from 4 analysts is $19.75, 0.4% below the current price of $19.83 Targets range from $19.00 to $20.00.
Is Silence Therapeutics a buy according to analysts?
The consensus rating is “Hold” (1 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Silence Therapeutics expected to earn?
Analysts expect EPS of $-1.03 for the fiscal year ending December 31, 2026 and $-0.80 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.